Issue 24, 2023
From the journal:

Nanoscale Advances

Hybrid AuNPs-3MPS-MTX nanosystem and its evaluation for treating cervical cancer and melanoma

M. J. Hernández-Esparza,ab   Ilaria Fratoddi, ORCID logo b   Sara Cerra, ORCID logo b   K. Juarez-Moreno ORCID logo *c  and  R. Huirache-Acuña ORCID logo *a  

* Corresponding authors

a Facultad de Ingeniería Química, Universidad Michoacana de San Nicolás de Hidalgo, Ciudad Universitaria, Morelia, Mexico
E-mail: rafael.huirache@umich.mx

b Department of Chemistry, University Sapienza of Rome, p. Aldo Moro 5, 00185 Rome, Italy

c Centro de Física Aplicada y Tecnología Avanzada, Universidad Nacional Autónoma de México, Mexico
E-mail: kjuarez@fata.unam.mx

Abstract

This research presents an evaluation of a hybrid material based on gold nanoparticles (AuNPs), stabilized with the thiol 3-mercapto-propanesulfonate (3MPS) and loaded with the methotrexate drug (MTX). The AuNPs-3MPS-MTX nanosystem was tested for the treatment of cervical cancer and melanoma, using the B16-F10 melanoma and HeLa cell lines. The tests performed on cell cultures assessed the efficiency of the studied nanosystem on tumor cells, as well as its toxicology.

Graphical abstract: Hybrid AuNPs-3MPS-MTX nanosystem and its evaluation for treating cervical cancer and melanoma

About
Cited by
Related
Download options Please wait...

Article information

DOI
https://doi.org/10.1039/D3NA00605K
Article type
Paper
Submitted
06 আগষ্ট 2023
Accepted
16 নবে 2023
First published
17 নবে 2023
This article is Open Access
Creative Commons BY-NC license

Nanoscale Adv., 2023,5, 7077-7085

Permissions

Request permissions

Hybrid AuNPs-3MPS-MTX nanosystem and its evaluation for treating cervical cancer and melanoma

M. J. Hernández-Esparza, I. Fratoddi, S. Cerra, K. Juarez-Moreno and R. Huirache-Acuña, Nanoscale Adv., 2023, 5, 7077 DOI: 10.1039/D3NA00605K

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements